Recruiting NCT07200778
Reducing Operative Blood Loss in Laparoscopic Myomectomy With Umbilico-uterine Trunk Clipping
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: umbilico-uterine trunk occlusion, local epinephrine infiltration.
- Who it may be relevant to
- Registry conditions: Laparoscopic Myomectomy. Basic parameters: 19 years — 45 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
the purpose of this study is to examine how Umbilico-uterine trunk occlusion reduces surgery-associated blood loss in Laparoscopic Myomectomy.
Interventions
- Procedure umbilico-uterine trunk occlusion
participants will undergo umbilico-uterine trunk occlusion during laparoscopic myomectomy - Procedure local epinephrine infiltration
participants will undergo local injections of epinephrine into the serosal and/or myometrium, covering the myoma before the uterine incision during laparoscopic myomectomy
Primary outcome measures
- Operative Blood Loss [Time frame: during operation]
- Hemoglobin drop [Time frame: 24 hours postoperative]
Eligibility criteria
Inclusion criteria
- Age between 19 and 45
- Symptoms of menorrhagia, pelvic pain, or infertility
- Plan to have a laparoscopic myomectomy
- Number of myomas ≤ 4, with the largest myoma measuring ≤ 9 cm
Exclusion criteria
- Postmenopausal status
- Dominant pedunculated subserosal FIGO classification (6-7)
- Submucosal type of myoma FIGO classification (0-2)
- Suspicion of malignant uterine or adnexal diseases
- Major medical comorbidities or psychiatric illnesses that could affect follow-up and/or compliance
- Refusal to participate or provide consent to the procedures.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Double blind
- Primary purpose
- Prevention
Study locations
Egypt · 1 center
- Minia advanced laparoscopy unit — Minya
Identifiers
NCT: NCT07200778 · 1531-5-2025